Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy: A randomised study

Panminerva Medica

Volumn 44, Issue 2, 2002, Pages 145-147

  Palmas, F ^a   Pellicano, R ^a   Massimetti, E ^a   Berrutti, M ^a   Fagoonee, S ^b   Rizzetto, M ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Duodenal ulcer, diagnosis; Duodenal ulcer, drug therapy; Helicobacter pylori; Peptic ulcer

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; PROTON PUMP;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG COMBINATION; DUODENUM ULCER; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AMOXICILLIN; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROTON PUMPS;

EID: 0036617893     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996;110:1244-52.
2. The European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997;41:8-13.
3. Lind T, Veldhuyzen van Zenten S, Unge P, Spiller R, Bayerdorffer E, O'Morain C et al. Eradication of Helicobacter pylori using one week triple therapies combining omeprazole with 2 antimicrobials. The MACH I study. Helicobacter 1996;1(3):138-44.
4. Cammarota G, Cianci R, Gasbarrini G. Eradication of Helicobacter pylori in routine clinical practice: doubts and uncertainties. Hepatogastroenterology 1999;46:312-5.
5. Pellicano R, Arena V, Palmas F, Gardino L, Greco S, Carucci P et al. Low-cost eradication for Helicobacter pylori infection in duodenal ulcer and gastritis. Ital J Gastroenterol Hepatol 1997; 29(2): A218/161.
6. Morgando A, Ponzetto A, Palmas F, Pellicano R, Repici A, Musso A et al. Long term follow-up after H. pylori eradication: results of a prospective study. Gastroenterology 2000;118(2):2676.
7. 13C-Urea Breat Test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol 1991;3:915-21.
8. McColl KEL, El-Omar EM, Gillen D. The role of H. pylori infection in the pathophysiology of duodenal ulcer disease. J Physiol Pharmacol 1997;48:287-95.
9. Mitchell HM, Hu P, Chi Y, Chen MH, Li YY, Hazell SL. A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China). Gastroenterology 1998;114:256-61.
10. Pellicano R, Palmas F, Arena V, Demarchi B, Leone N, Rizzetto M et al. Lack of reinfection after Helicobacter pylori eradication in duodenal ulcer disease: a prospective study from Turin (Italy). Ann Saudi Med 1999;19:376-7.
11. Jönsson B. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease. Scand J Gastroenterol 1996; 31(215):90-5.
12. Terranova R, Luca S. Helicobacter pylori eradication in elderly patients. Minerva Gastroenterol Dietol 2000;46:7-13.
13. Moayyedi P, Sahay P, Tompkins D, Axon ATR. Efficacy and optimum dosage of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995;7:835-40.
14. Alarcon T, Domingo D, Lopez-Brea M. Antibiotic resistance problems with Helicobacter pylori. Int J Antimicrobial Agents 1999;12:19-26.
15. Maconi G, Russo A, Imbesi V, Cucino C, Bianchi Porro G. Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from 1 to 2 weeks in duodenal ulcer: is it worthwhile? Digest Liver Dis 2000;32:275-80.
16. Bigard MA, Delchier JC, Riachi G, Thibault P, Barthelemy P. One-week therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin. Aliment Pharmacol Ther 1998;12:383-8.
17. Bazzoli F, Zagari M, Pozzato P, Varoli O, Fossi S, Ricciardiello et al. Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomised, double-blind, controlled study. Aliment Pharmacol Ther 1998;12:439-45.
18. Rinaldi V, Zullo A, De Francesco V, Hassan C, Winn S, Stoppino V et al. Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy. Aliment Pharmacol Ther 1999;13:163-8.
19. Lee JM, Deasy E, O'Morain CA. Helicobacter pylori eradication therapy: a discrepancy between current guidelines and clinical practice. Eur J Gastroenterol Hepatol 2000;12:433-7.
20. Auriemma L, Signorelli S. The role of tetracycline in the retreatment after Helicobacter pylori eradication failure. Minerva Med 2001;92:145-9.